The global market for Nuclear Radiation Therapeutic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.

North American market for Nuclear Radiation Therapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nuclear Radiation Therapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nuclear Radiation Therapeutic Drugs include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Radiation Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Radiation Therapeutic Drugs.

The Nuclear Radiation Therapeutic Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Radiation Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Radiation Therapeutic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Radiation Therapeutic Drugs Market Report

Report Metric	Details
Report Name	Nuclear Radiation Therapeutic Drugs Market
Segment by Type	Diagnostic Therapeutic
Segment by Application	Oncology Thyroid Cardiology Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Radiation Therapeutic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Radiation Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nuclear Radiation Therapeutic Drugs Market report?

Ans: The main players in the Nuclear Radiation Therapeutic Drugs Market are Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

What are the Application segmentation covered in the Nuclear Radiation Therapeutic Drugs Market report?

Ans: The Applications covered in the Nuclear Radiation Therapeutic Drugs Market report are Oncology, Thyroid, Cardiology, Others

What are the Type segmentation covered in the Nuclear Radiation Therapeutic Drugs Market report?

Ans: The Types covered in the Nuclear Radiation Therapeutic Drugs Market report are Diagnostic, Therapeutic

1 Nuclear Radiation Therapeutic Drugs Market Overview

1.1 Product Definition

1.2 Nuclear Radiation Therapeutic Drugs by Type

1.2.1 Global Nuclear Radiation Therapeutic Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Nuclear Radiation Therapeutic Drugs by Application

1.3.1 Global Nuclear Radiation Therapeutic Drugs Market Value by Application (2024 VS 2031)

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Global Nuclear Radiation Therapeutic Drugs Market Size Estimates and Forecasts

1.4.1 Global Nuclear Radiation Therapeutic Drugs Revenue 2020-2031

1.4.2 Global Nuclear Radiation Therapeutic Drugs Sales 2020-2031

1.4.3 Global Nuclear Radiation Therapeutic Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Nuclear Radiation Therapeutic Drugs Market Competition by Manufacturers

2.1 Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nuclear Radiation Therapeutic Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nuclear Radiation Therapeutic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Product Type & Application

2.7 Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Date of Enter into This Industry

2.8 Global Nuclear Radiation Therapeutic Drugs Market Competitive Situation and Trends

2.8.1 Global Nuclear Radiation Therapeutic Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nuclear Radiation Therapeutic Drugs Players Market Share by Revenue

2.8.3 Global Nuclear Radiation Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nuclear Radiation Therapeutic Drugs Market Scenario by Region

3.1 Global Nuclear Radiation Therapeutic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nuclear Radiation Therapeutic Drugs Sales by Region: 2020-2031

3.2.1 Global Nuclear Radiation Therapeutic Drugs Sales by Region: 2020-2025

3.2.2 Global Nuclear Radiation Therapeutic Drugs Sales by Region: 2026-2031

3.3 Global Nuclear Radiation Therapeutic Drugs Revenue by Region: 2020-2031

3.3.1 Global Nuclear Radiation Therapeutic Drugs Revenue by Region: 2020-2025

3.3.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Region: 2026-2031

3.4 North America Nuclear Radiation Therapeutic Drugs Market Facts & Figures by Country

3.4.1 North America Nuclear Radiation Therapeutic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2031)

3.4.3 North America Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nuclear Radiation Therapeutic Drugs Market Facts & Figures by Country

3.5.1 Europe Nuclear Radiation Therapeutic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2031)

3.5.3 Europe Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nuclear Radiation Therapeutic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Nuclear Radiation Therapeutic Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nuclear Radiation Therapeutic Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Nuclear Radiation Therapeutic Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Nuclear Radiation Therapeutic Drugs Market Facts & Figures by Country

3.7.1 Latin America Nuclear Radiation Therapeutic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2031)

3.7.3 Latin America Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Nuclear Radiation Therapeutic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Nuclear Radiation Therapeutic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nuclear Radiation Therapeutic Drugs Sales by Type (2020-2031)

4.1.1 Global Nuclear Radiation Therapeutic Drugs Sales by Type (2020-2025)

4.1.2 Global Nuclear Radiation Therapeutic Drugs Sales by Type (2026-2031)

4.1.3 Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Type (2020-2031)

4.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Type (2020-2031)

4.2.1 Global Nuclear Radiation Therapeutic Drugs Revenue by Type (2020-2025)

4.2.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Type (2026-2031)

4.2.3 Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Nuclear Radiation Therapeutic Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nuclear Radiation Therapeutic Drugs Sales by Application (2020-2031)

5.1.1 Global Nuclear Radiation Therapeutic Drugs Sales by Application (2020-2025)

5.1.2 Global Nuclear Radiation Therapeutic Drugs Sales by Application (2026-2031)

5.1.3 Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Application (2020-2031)

5.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Application (2020-2031)

5.2.1 Global Nuclear Radiation Therapeutic Drugs Revenue by Application (2020-2025)

5.2.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Application (2026-2031)

5.2.3 Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Nuclear Radiation Therapeutic Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Nihon Medi-Physics Co.,Ltd.

6.1.1 Nihon Medi-Physics Co.,Ltd. Company Information

6.1.2 Nihon Medi-Physics Co.,Ltd. Description and Business Overview

6.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product Portfolio

6.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates

6.2 Curium Pharma

6.2.1 Curium Pharma Company Information

6.2.2 Curium Pharma Description and Business Overview

6.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs Product Portfolio

6.2.5 Curium Pharma Recent Developments/Updates

6.3 Cardinal Health

6.3.1 Cardinal Health Company Information

6.3.2 Cardinal Health Description and Business Overview

6.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs Product Portfolio

6.3.5 Cardinal Health Recent Developments/Updates

6.4 Bayer Global

6.4.1 Bayer Global Company Information

6.4.2 Bayer Global Description and Business Overview

6.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs Product Portfolio

6.4.5 Bayer Global Recent Developments/Updates

6.5 GE Healthcare

6.5.1 GE Healthcare Company Information

6.5.2 GE Healthcare Description and Business Overview

6.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs Product Portfolio

6.5.5 GE Healthcare Recent Developments/Updates

6.6 Mallinckrodt Pharmaceuticals

6.6.1 Mallinckrodt Pharmaceuticals Company Information

6.6.2 Mallinckrodt Pharmaceuticals Description and Business Overview

6.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Product Portfolio

6.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates

6.7 Bracco Group

6.7.1 Bracco Group Company Information

6.7.2 Bracco Group Description and Business Overview

6.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs Product Portfolio

6.7.5 Bracco Group Recent Developments/Updates

6.8 Advanced Molecular-imaging Solution

6.8.1 Advanced Molecular-imaging Solution Company Information

6.8.2 Advanced Molecular-imaging Solution Description and Business Overview

6.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Product Portfolio

6.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates

6.9 Ciaeriar

6.9.1 Ciaeriar Company Information

6.9.2 Ciaeriar Description and Business Overview

6.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs Product Portfolio

6.9.5 Ciaeriar Recent Developments/Updates

6.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

6.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information

6.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Description and Business Overview

6.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product Portfolio

6.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nuclear Radiation Therapeutic Drugs Industry Chain Analysis

7.2 Nuclear Radiation Therapeutic Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nuclear Radiation Therapeutic Drugs Production Mode & Process Analysis

7.4 Nuclear Radiation Therapeutic Drugs Sales and Marketing

7.4.1 Nuclear Radiation Therapeutic Drugs Sales Channels

7.4.2 Nuclear Radiation Therapeutic Drugs Distributors

7.5 Nuclear Radiation Therapeutic Drugs Customer Analysis

8 Nuclear Radiation Therapeutic Drugs Market Dynamics

8.1 Nuclear Radiation Therapeutic Drugs Industry Trends

8.2 Nuclear Radiation Therapeutic Drugs Market Drivers

8.3 Nuclear Radiation Therapeutic Drugs Market Challenges

8.4 Nuclear Radiation Therapeutic Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Nihon Medi-Physics Co.,Ltd.

Mallinckrodt Pharmaceuticals

Bracco Group

Advanced Molecular-imaging Solution

Ciaeriar

Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

List of Tables

Table 1. Global Nuclear Radiation Therapeutic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nuclear Radiation Therapeutic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Nuclear Radiation Therapeutic Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Nuclear Radiation Therapeutic Drugs Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Nuclear Radiation Therapeutic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Nuclear Radiation Therapeutic Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Nuclear Radiation Therapeutic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Nuclear Radiation Therapeutic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Nuclear Radiation Therapeutic Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nuclear Radiation Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiation Therapeutic Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nuclear Radiation Therapeutic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nuclear Radiation Therapeutic Drugs Sales by Region (2020-2025) & (Units)

Table 18. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Nuclear Radiation Therapeutic Drugs Sales by Region (2026-2031) & (Units)

Table 20. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Nuclear Radiation Therapeutic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Nuclear Radiation Therapeutic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Nuclear Radiation Therapeutic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2025) & (Units)

Table 27. North America Nuclear Radiation Therapeutic Drugs Sales by Country (2026-2031) & (Units)

Table 28. North America Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Nuclear Radiation Therapeutic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Nuclear Radiation Therapeutic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2025) & (Units)

Table 32. Europe Nuclear Radiation Therapeutic Drugs Sales by Country (2026-2031) & (Units)

Table 33. Europe Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Nuclear Radiation Therapeutic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Nuclear Radiation Therapeutic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Nuclear Radiation Therapeutic Drugs Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Nuclear Radiation Therapeutic Drugs Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Nuclear Radiation Therapeutic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Nuclear Radiation Therapeutic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nuclear Radiation Therapeutic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2025) & (Units)

Table 42. Latin America Nuclear Radiation Therapeutic Drugs Sales by Country (2026-2031) & (Units)

Table 43. Latin America Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nuclear Radiation Therapeutic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Nuclear Radiation Therapeutic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Nuclear Radiation Therapeutic Drugs Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Nuclear Radiation Therapeutic Drugs Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Nuclear Radiation Therapeutic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Nuclear Radiation Therapeutic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Nuclear Radiation Therapeutic Drugs Sales (Units) by Type (2020-2025)

Table 51. Global Nuclear Radiation Therapeutic Drugs Sales (Units) by Type (2026-2031)

Table 52. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Nuclear Radiation Therapeutic Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Nuclear Radiation Therapeutic Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Nuclear Radiation Therapeutic Drugs Sales (Units) by Application (2020-2025)

Table 61. Global Nuclear Radiation Therapeutic Drugs Sales (Units) by Application (2026-2031)

Table 62. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Nuclear Radiation Therapeutic Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Nuclear Radiation Therapeutic Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Nuclear Radiation Therapeutic Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Nuclear Radiation Therapeutic Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Nihon Medi-Physics Co.,Ltd. Company Information

Table 71. Nihon Medi-Physics Co.,Ltd. Description and Business Overview

Table 72. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product

Table 74. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates

Table 75. Curium Pharma Company Information

Table 76. Curium Pharma Description and Business Overview

Table 77. Curium Pharma Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Curium Pharma Nuclear Radiation Therapeutic Drugs Product

Table 79. Curium Pharma Recent Developments/Updates

Table 80. Cardinal Health Company Information

Table 81. Cardinal Health Description and Business Overview

Table 82. Cardinal Health Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Cardinal Health Nuclear Radiation Therapeutic Drugs Product

Table 84. Cardinal Health Recent Developments/Updates

Table 85. Bayer Global Company Information

Table 86. Bayer Global Description and Business Overview

Table 87. Bayer Global Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Bayer Global Nuclear Radiation Therapeutic Drugs Product

Table 89. Bayer Global Recent Developments/Updates

Table 90. GE Healthcare Company Information

Table 91. GE Healthcare Description and Business Overview

Table 92. GE Healthcare Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. GE Healthcare Nuclear Radiation Therapeutic Drugs Product

Table 94. GE Healthcare Recent Developments/Updates

Table 95. Mallinckrodt Pharmaceuticals Company Information

Table 96. Mallinckrodt Pharmaceuticals Description and Business Overview

Table 97. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Product

Table 99. Mallinckrodt Pharmaceuticals Recent Developments/Updates

Table 100. Bracco Group Company Information

Table 101. Bracco Group Description and Business Overview

Table 102. Bracco Group Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Bracco Group Nuclear Radiation Therapeutic Drugs Product

Table 104. Bracco Group Recent Developments/Updates

Table 105. Advanced Molecular-imaging Solution Company Information

Table 106. Advanced Molecular-imaging Solution Description and Business Overview

Table 107. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Product

Table 109. Advanced Molecular-imaging Solution Recent Developments/Updates

Table 110. Ciaeriar Company Information

Table 111. Ciaeriar Description and Business Overview

Table 112. Ciaeriar Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Ciaeriar Nuclear Radiation Therapeutic Drugs Product

Table 114. Ciaeriar Recent Developments/Updates

Table 115. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information

Table 116. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Description and Business Overview

Table 117. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product

Table 119. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Nuclear Radiation Therapeutic Drugs Distributors List

Table 123. Nuclear Radiation Therapeutic Drugs Customers List

Table 124. Nuclear Radiation Therapeutic Drugs Market Trends

Table 125. Nuclear Radiation Therapeutic Drugs Market Drivers

Table 126. Nuclear Radiation Therapeutic Drugs Market Challenges

Table 127. Nuclear Radiation Therapeutic Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nuclear Radiation Therapeutic Drugs

Figure 2. Global Nuclear Radiation Therapeutic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nuclear Radiation Therapeutic Drugs Market Share by Type: 2024 & 2031

Figure 4. Diagnostic Product Picture

Figure 5. Therapeutic Product Picture

Figure 6. Global Nuclear Radiation Therapeutic Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Nuclear Radiation Therapeutic Drugs Market Share by Application: 2024 & 2031

Figure 8. Oncology

Figure 9. Thyroid

Figure 10. Cardiology

Figure 11. Others

Figure 12. Global Nuclear Radiation Therapeutic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Nuclear Radiation Therapeutic Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Nuclear Radiation Therapeutic Drugs Sales (2020-2031) & (Units)

Figure 15. Global Nuclear Radiation Therapeutic Drugs Average Price (US$/Unit) & (2020-2031)

Figure 16. Nuclear Radiation Therapeutic Drugs Report Years Considered

Figure 17. Nuclear Radiation Therapeutic Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Nuclear Radiation Therapeutic Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Nuclear Radiation Therapeutic Drugs Players: Market Share by Revenue in Nuclear Radiation Therapeutic Drugs in 2024

Figure 20. Nuclear Radiation Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Nuclear Radiation Therapeutic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Nuclear Radiation Therapeutic Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Nuclear Radiation Therapeutic Drugs Revenue Market Share by Country (2020-2031)

Figure 24. United States Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Nuclear Radiation Therapeutic Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Nuclear Radiation Therapeutic Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Nuclear Radiation Therapeutic Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Nuclear Radiation Therapeutic Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Nuclear Radiation Therapeutic Drugs Sales Market Share by Country (2020-2031)

Figure 43. Latin America Nuclear Radiation Therapeutic Drugs Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Nuclear Radiation Therapeutic Drugs Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Nuclear Radiation Therapeutic Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Nuclear Radiation Therapeutic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Nuclear Radiation Therapeutic Drugs by Type (2020-2031)

Figure 54. Global Revenue Market Share of Nuclear Radiation Therapeutic Drugs by Type (2020-2031)

Figure 55. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Nuclear Radiation Therapeutic Drugs by Application (2020-2031)

Figure 57. Global Revenue Market Share of Nuclear Radiation Therapeutic Drugs by Application (2020-2031)

Figure 58. Global Nuclear Radiation Therapeutic Drugs Price (US$/Unit) by Application (2020-2031)

Figure 59. Nuclear Radiation Therapeutic Drugs Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Nuclear Radiation Therapeutic Drugs Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-37K14010

Global Nuclear Radiation Therapeutic Drugs Market Research Report 2025

FEATURED COMPANIES

Nuclear Radiation Therapeutic Drugs Market

Report Scope

Scope of Nuclear Radiation Therapeutic Drugs Market Report

Core Chapters

FAQ for this report

Who are the main players in the Nuclear Radiation Therapeutic Drugs Market report?

What are the Application segmentation covered in the Nuclear Radiation Therapeutic Drugs Market report?

What are the Type segmentation covered in the Nuclear Radiation Therapeutic Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS